ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

Publication Type:

Journal Article

Source:

The New England journal of medicine, Volume 369, Issue 6, p.529-39 (2013)

Keywords:

2013, August 2013, Biological Markers, Graft vs Host Disease, hematopoietic stem cell transplantation, Humans, Middle Aged, Public Health Sciences Division, Receptors, Cell Surface, RECURRENCE, Risk Assessment, Risk Factors, Transplantation, Homologous

Abstract:

No plasma biomarkers are associated with the response of acute graft-versus-host disease (GVHD) to therapy after allogeneic hematopoietic stem-cell transplantation.